1 – 85 of 85
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Healthcare Services for Asylum-Seekers: Untangling the European Social Charter
(
- Contribution to journal › Article
-
Mark
What Healthcare Services Temporary Protection Entitles to Have? Navigating the European Social Charter
(
- Contribution to journal › Article
-
Mark
Folkrätten i svensk medicinsk rätt
2024) p.263-283(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2023
-
Mark
Governing, Protecting, and Regulating the Future of Genome Editing : The Significance of ELSPI Perspectives
Slokenberga, Santa ; Minssen, Timo and Nordberg, Ana LU (2023)
- Book/Report › Anthology (editor)
-
Mark
Kirurg döms för misshandel efter att ha genomfört transplantationer av syntetiska luftstrupar i strid med vetenskap och beprövad erfarenhet
2023) In JP Infonet(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Vem prioriterar i svensk sjukvård?
(
- Contribution to journal › Article
-
Mark
An Ounce of Prevention for a Pound of Cure? Infection Disease Testing at the Border
2023) p.251-263(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2022
-
Mark
Governing, protecting, and regulating the future of genome editing : The significance of ELSI perspectives
(
- Contribution to journal › Article
-
Mark
Arbetsvillkor för god vård - arbetsrätten i hälso- och sjukvården
2022) p.85-101(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Employee Health Data in European Law : Privacy is (not) an Option?
(
- Contribution to journal › Article
-
Mark
Samtycke och beslutskompetens i vården
2022) p.119-134(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Smittskydd
2022) p.203-218(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Vård i livets slutskede
2022) p.307-320(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Klinisk forskning
2022) p.271-288(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
E-hälsa
2022) p.153-168(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2021
-
Mark
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper
2021)(
- Book/Report › Report
- 2020
-
Mark
Special issue on legal landscape concerning the coronavirus outbreak – part II
2020) 2020:2.(
- Other contribution › Miscellaneous
-
Mark
Country Reports
(
- Contribution to journal › Article
-
Mark
Biobanking and data transfer between the EU and Cape Verde, Mauritius, Morocco, Senegal and Tunisia. Adequacy considerations and Convention 108
(
- Contribution to journal › Article
-
Mark
Genetiska interventioner inom och utanför hälso- och sjukvården
2020)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Setting the foundations: Individual rights, public interest, scientific research and biobanking
2020)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Individual rights, public interest and biobanking. Article 89 GDPR and European legal responses
Slokenberga, Santa LU ; Tzortzatou, Olga and Reichel, Jane (2020)
- Book/Report › Anthology (editor)
-
Mark
Medicinsk rätt : En lärobok
Zillen, Kavot ; Mattsson, Titti LU and Slokenberga, Santa LU (2020)
- Book/Report › Anthology (editor)
-
Mark
To force or not to force: protecting the lives of persons with dementia who refuse care
2020) p.465-485(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Klinisk forskning
2020)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Vård i livets slutskede
2020)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
E-hälsa
2020) p.119-133(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
COVID-19 Pandemic in Sweden : Measures, Policy approach and Legal and Ethical debates
(
- Contribution to journal › Article
-
Mark
Samtycke och beslutskompetens i vården
2020) p.85-99(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Social, cultural and economic aspects of antimicrobial resistance
(
- Contribution to journal › Article
-
Mark
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
(
- Contribution to journal › Article
-
Mark
ELSI Implications of Prioritizing Biological Therapies in the Times of COVID-19
(
- Contribution to journal › Article
-
Mark
Ethical and Legal Challenges of Artificial Intelligence-Driven Health Care
2020) p.295-336(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges: Available at: https://blog.petrieflom.law.harvard.edu/2020/05/12/sweden-global-responses-covid19/
2020)(
- Other contribution › Miscellaneous
-
Mark
Establishing the First International Genetic Discrimination Observatory
(
- Contribution to journal › Article
-
Mark
Clinical trial data transparency and GDPR compliance: Implications for data sharing and open innovation
2020) In Science and Public Policy(
- Contribution to journal › Article
-
Mark
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?
(
- Contribution to journal › Article
-
Mark
Applying the Proportionality Principle to COVID-19 Antibody Testing
2020) In Journal of Law and the Biosciences(
- Contribution to journal › Article
-
Mark
Regulatory responses to medical machine learning
(
- Contribution to journal › Article
- 2019
-
Mark
The GDPR and the research exemption: considerations on the necessary safeguards for research biobanks
2019) In European Journal of Human Genetics(
- Contribution to journal › Article
-
Mark
13.pants. Nepilngadīga pacienta tiesības
2019)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Three Hundred Years of Legal Incapacity in Russia
2019)(
- Other contribution › Web publication
-
Mark
Ethical Questions in Gene Therapy
2019) p.525-531(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Nudges or Shoves in the Secondary Use of Health Data: What is the More Desirable Approach? (Part 2)
2019)(
- Other contribution › Miscellaneous
-
Mark
How does emerging patent case law in the US and Europe affect precision medicine?
(
- Contribution to journal › Article
-
Mark
Nudges or Shoves in the Secondary Use of Health Data: What is the More Desirable Approach? (Part I)
2019)(
- Other contribution › Miscellaneous
-
Mark
The Legal Dimensions of Big Data, Artificial Intelligence and Machine Learning in Pharmaceutical Innovation (original title in accepted version): Editorial to special issue of the European Pharmaceutical Law Review on "Big Data, AI & Machine Learning in Pharmaceutial Innovation"
(
- Contribution to journal › Article
-
Mark
AIPPI Report for Denmark on Plausibility in Patent Law: AIPPI 2019 - 2019 Study Questions - Plausibility
2019)(
- Book/Report › Book
-
Mark
The problem with antibiotics
(
- Contribution to journal › Article
-
Mark
Is Data Sharing Caring Enough About Patient Privacy?: Part I: The Background
2019)(
- Other contribution › Miscellaneous
-
Mark
What lurks in the shadows of the openness hyperbole for biopharmaceuticals?
2019) In Drug Development Research(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine
(
- Contribution to journal › Article
-
Mark
An Update on Research- & Bolar exemptions in the U.S. and Europe: Unsolved questions and new developments in an increasingly important area of law
(
- Contribution to journal › Article
-
Mark
Global Genes, Local Concerns: Legal, Ethical and Scientific Challenges in International Biobanking
2019)(
- Book/Report › Book
-
Mark
Much ado about something. Legal, ethical, and scientific challenges in international biobanking and translational exploitation
2019) 1.(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Shadow health records meet new data privacy laws
(
- Contribution to journal › Article
-
Mark
An "export-only" exception to pharmaceutical patents in Europe: Should the U.S. follow suit?
(
- Contribution to journal › Article
-
Mark
Homomorphic Encryption: The ‘Holy Grail’ for Big Data Analytics & Legal Compliance in the Pharmaceutical and Healthcare Sector?
(
- Contribution to journal › Article
- 2018
-
Mark
Pacientu tiesību likuma komentāri
Slokenberga, Santa LU (2018)
- Book/Report › Anthology (editor)
-
Mark
A Ray of Light in Muddy Waters? -The CJEU rules on combination SPCs in C-121/17 Teva v Gilead
(
- Contribution to journal › Article
-
Mark
How much is too much?- Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector
(
- Contribution to journal › Article
-
Mark
Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
2018) In Life Sciences Intellectual Property Review (LSIPR)(
- Contribution to journal › Article
-
Mark
Big Data in the Health and Life Sciences: What Are the Challenges for European Competition Law and Where Can They Be Found?
2018) In CEIPI / ICTSD Publication Series on Global Perspectives and Challenges for the Intellectual Property System p.121-130(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
The Rights of Children in Biomedicine : Challenges posed by scientific advances and uncertainties
2017)(
- Book/Report › Report
- 2016
-
Mark
Lost in Translation: Interpretation of Legal Capacity in Ukraine
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Medicīnas tiesības
Slokenberga, Santa LU (2015)
- Book/Report › Anthology (editor)
-
Mark
Ārstniecība cilvēka dzīves nogalē un nāves tiesiskie aspekti
2015) p.639-675(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Will clinical trial data disclosure reduce incentives to develop new uses of drugs?
(
- Contribution to journal › Article
-
Mark
IPRs in Biobanking: Risks and Opportunities for Translational Research
(
- Contribution to journal › Article
-
Mark
A “ray of hope” for European stem cell patents or “out of the smog into the fog”?: The CJEU decision in C-364/13 and how it compares to recent US developments.(under review)
2015) In Biotechnology Law Report(
- Contribution to journal › Article
-
Mark
Synthetic biology and intellectual property rights: Six recommendations
(
- Contribution to journal › Article
- 2014
-
Mark
Medical Aid in dying in Quebec : legal considerations
2014) In Journal of Medical Law and Ethics(
- Contribution to journal › Article
-
Mark
Определение дееспособности пациентов в различных правовых системах
2014) p.115-120(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Book Review: Drexl, J., Lee, N. (2013). Pharmaceutical Innovation, Competition and Patent Law : A Trilateral Perspective. Edward Elgar Publishing
(
- Contribution to journal › Review (Book/Film/Exhibition/etc.)
-
Mark
Legal aspects of biobanking as key issues for personalized medicine and translational exploitation
(
- Contribution to journal › Article
- 2013
-
Mark
Yttrandefrihet och personlig integritet inom hälso- och sjukvården: rättsliga aspekter
2013) p.33-50(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Remissyttrande: Delbetänkandet Patientlag (SOU 2013:2)
2013)(
- Other contribution › Consultation response
- 2012
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO--Part II1
(
- Contribution to journal › Article
-
Mark
Remissvar: till betänkandet DS 2012:46 Avkaffande av steriliseringskrav som villkor för ändrad könstillhörighet
2012)(
- Other contribution › Consultation response
- 2010
-
Mark
Генезис законодавства про допуск до медичної діяльності в деяких країнах світу до 1914 року
(
- Contribution to journal › Article
-
Mark
Законодавче регулювання питань народної медицини щодо паліативної допомоги
2010) p.122-126(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Meanwhile on the Other Side of the Pond: Why Biopharmaceutical Inventions that Were'Obvious to Try'Still Might Be Non-Obvious--Part I
(
- Contribution to journal › Article
- 2008
-
Mark
Es bleibet dabei: Eine schwedische Stellungnahme zur europäischen Debatte über den absoluten Erzeugnisschutz bei der DNA-Patentierung--Teil 2
(
- Contribution to journal › Article
-
Mark
Es bleibet dabei: Eine schwedische Stellungnahme zur europäischen Debatte über den absoluten Erzeugnisschutz bei der DNA-Patentierung – Teil 1
(
- Contribution to journal › Article
- 2007
-
Mark
Barnets rätt, vårdnadshavarnas rätt eller samhällets rätt? Intressekonflikter i det barnpsykiatriska vårdarbetet
2007)(
- Working paper/Preprint › Working paper